hotspot -WSS

hotspot

author：leisure time 2025-09-30 18:42:54 - browse：45

Chris O'Meara/AP

Johnson & Johnson faces a consequential new class action lawsuit — not in its role as a manufacturer of drugs, but as an employer and purchaser of prescription drugs for its workers.

Ann Lewandowski, a health care policy and advocacy director at J&J, sued her company on Monday for allegedly overpaying its pharmacy benefit manager for its employees’ medicines, citing previous STAT reporting to support some of the allegations. Those overpayments, the lawsuit alleges, ultimately come out of workers’ paychecks in the form of high health insurance premiums, higher out-of-pocket drug costs, and stunted wage growth.

In one example, J&J allegedly paid its PBM more than $10,000 for a single 90-day prescription of teriflunomide, a generic medicine for multiple sclerosis, when that same 90-day prescription could be purchased for as little as $30 elsewhere without insurance, according to the lawsuit.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Ukraine seeks to reclaim its role as a hub for clinical trials

hotspot

WSS

Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

Adele warns fans about throwing things at performers onstage

Condition critical? Britain's beloved but battered National Health Service turns 75

Bipartisan group of lawmakers warns of a rising Chinese threat to U.S. biotech

In 'major milestone,' FDA approves first cell therapy for solid tumors

Readout LOUD podcast: Pharma in Washington, Alnylam, and Gilead

focus

hotspot

focus

Tori Bowie and the unacceptable rates of Black maternal death

Congress may force more Covid

As demand for Covid shots wanes, Moderna seeks its next success

MD Anderson's Padmanee Sharma responds to research credit suit

Drug repurposing or repositioning? The language matters

Dramatic video released of Russian fighter jets 'harassing' US drones over Syria

Medical records are filled with copy

MD Anderson's Padmanee Sharma responds to research credit suit

Duchenne breakthrough therapy leaves behind pioneering families

Dramatic video released of Russian fighter jets 'harassing' US drones over Syria

focus

Adele warns fans about throwing things at performers onstage

Former New York Mayor de Blasio and wife announce separation, but not divorce

2 million sign

A new drug could help frostbite victims avoid its ravages

Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

1 in 4 Americans hadn't contracted COVID by the end of 2022, CDC estimates

knowledge

hotspot

focus

leisure time